Myelodysplastic Syndromes

This page contains recent news articles, when available, and an overview of Myelodysplastic Syndromes but does not offer medical advice. You should contact your physician with regard to any health issues or concerns.

News: Myelodysplastic Syndromes

Latest MDS Research To Be Presented At The 51st Meeting Of The American ...  -  23 Nov 2009
The MDS BeaconExperts will discuss the latest research for various blood diseases, including myelodysplastic syndromes (MDS), at the 51 st annual meeting of the American ...

CytRx: Technical Breakout Imminent  -  23 Nov 2009
Seeking Alpha (blog)...myelodysplastic syndrome and certain solid tumors in the US, and multiple myeloma, myelodysplastic syndromes and solid tumors other than hepatocellular ...

Amgen Recognized for Best Pipeline and Best New Drug at Scrip Awards  -  23 Nov 2009
PR Newswire (press release)It is also being investigated for potential use in pediatric ITP, myelodysplastic syndromes (MDS) and chemotherapy-induced thrombocytopenia (CIT). ...

The H1N1 Swine Flu Vaccine And Myelodysplastic Syndromes: A Comprehensive Review  -  ‎Nov 5, 2009‎
The MDS BeaconWith the flu season upon us, myelodysplastic syndromes (MDS) patients are recommended to get the inactivated H1N1 flu shot vaccine, the seasonal flu vaccine ...

Featured Clinical Trial: Combination Therapy for Patients with Myelodysplastic ...  -  ‎Nov 17, 2009‎
National Cancer Institute - NCI Cancer BulletinPhase III Randomized Study of Lenalidomide with Versus without Epoetin Alfa in Patients with Low- or Intermediate-1-Risk Myelodysplastic Syndromes and ...

Myelodysplastic Syndromes  -  ‎Nov 4, 2009‎
New England Journal of Medicine (subscription)According to the 2008 World Health Organization (WHO) classification system for hematologic cancers, the primary myelodysplastic syndromes are one of five ...

Response After Revlimid Treatment Predicts Risk For AML In Certain ...  -  ‎Nov 9, 2009‎
The MDS BeaconEuropean researchers report that myelodysplastic syndromes (MDS) patients with deletion-5q syndrome (del-5q) have an increased risk of progressing to acute ...

Gene RPS14 Is Linked To Survival Of Patients With Myelodysplastic Syndromes  -  ‎Oct 28, 2009‎
The MDS BeaconScientists have found that the prognosis of a subset of myelodysplastic syndromes (MDS) patients may be affected by activation of the gene RPS14. ...

Centenary College to hold stem cell donor drive and benefit for ...  -  ‎Nov 16, 2009‎
Warren ReporterMyelodysplastic Syndromes (MDS) are a group of diseases that affect the bone marrow and blood. Some types of MDS are mild and easily managed, ...

School of Pharmacy Hopes to Close Clinical Gap for Elderly Blood Disorder  -  ‎Nov 2, 2009‎
UMB NewsThe challenge grant targets a widely accepted practice of controlling anemia that is associated with myelodysplastic syndromes (MDS) with erythropoietin, ...

UPDATE 1-US FDA warns Shire, Eisai on promotions  -  ‎Nov 13, 2009‎
Reuters..."presents numerous claims that misleadingly overstate the efficacy" of Dacogen, a drug for treating blood disorders known as myelodysplastic syndromes. ...

More In New Drug News  -  ‎Nov 17, 2009‎
American Journal of Hemotology and OncologyIndications: Myelodysplastic syndromes (refractory anemias, chronic myelomonocytic leukemia). • Adults: Premedicate for nausea & vomiting. ...

Cyclacel Pharmaceuticals Announces Third Quarter 2009 Financial Results  -  ‎Nov 3, 2009‎
ReutersWe continue to concentrate our efforts on advancing sapacitabine into Phase 3 development for AML and/or myelodysplastic syndromes (MDS) while preserving ...

Beacon NewsFlashes – November 3, 2009  -  ‎Nov 3, 2009‎
The MDS Beacon5th International Congress On Myeloproliferative Diseases And Myelodysplastic Syndromes — On November 5 through 7, the 5th International Congress on ...

Reduced-Intensity Drug Regimens Allow Stem Cell Transplantation In Elderly MDS ...  -  ‎Nov 18, 2009‎
The MDS Beacon...technologies permit the consideration of stem cell transplantation for myelodysplastic syndromes (MDS) patients who are older than 55 years. ...

www.Xtremepicks.Com: Xtremepicks Alerts November 17, 2009 : CYCC, VIRL, ARMH ...  -  ‎Nov 17, 2009‎
TMC Net...clinical trial results of sapacitabine for the treatment of advanced myeloid leukemia (AML) and myelodysplastic syndromes (MDS) will be presented at two ...

Researchers Investigate Acute Pulmonary Failure In MDS Patients  -  ‎Nov 15, 2009‎
The MDS Beacon...in Houston have investigated the occurrence of acute pulmonary failure for acute myeloid leukemia (AML) and myelodysplastic syndromes (MDS) patients. ...

Worker clears hurdles on inspirational journey  -  ‎Nov 16, 2009‎
Livingston DailyAmong his ailments, Roediger suffers from myelodysplastic syndromes, a group of diseases in which bone marrow doesn't produce enough healthy blood cells. ...

Cyclacel Pharmaceuticals Receives Deficiency Notice From Nasdaq Global Select ...  -  ‎Oct 30, 2009‎
Reuters...for the treatment of acute myeloid leukemia in the elderly, myelodysplastic syndromes and lung cancer and in Phase 1 in combination with seliciclib. ...

Ban On Payment For Bone Marrow Donations Challenged In Lawsuit  -  ‎Nov 12, 2009‎
The MDS BeaconAn overturn of the ban could have a large impact on physicians, donors, and especially patients, including those with myelodysplastic syndromes (MDS). ...

FDA Warns Shire, Eisai On Promotions  -  ‎Nov 16, 2009‎
Post Chronicle..."presents numerous claims that misleadingly overstate the efficacy" of Dacogen, a drug for treating blood disorders known as myelodysplastic syndromes. ...

Cyclacel Pharmaceuticals to Present Sapacitabine Phase 2 AML & MDS Data at the ...  -  ‎Nov 17, 2009‎
istockAnalyst.com (press release)...clinical trial results of sapacitabine for the treatment of advanced myeloid leukemia (AML) and myelodysplastic syndromes (MDS) will be presented at two ...

Array BioPharma Reports Financial Results for the First Quarter of Fiscal 2010  -  ‎Nov 2, 2009‎
WELT ONLINEARRY-614 - p38/Tie-2 Inhibitor for MDS: Array is dosing patients with myelodysplastic syndromes (MDS) in a Phase 1 trial with ARRY-614 to determine the ...

More Than 200 Abstracts Evaluating Celgene Products across a Range of ...  -  ‎Nov 11, 2009‎
WELT ONLINE...results in indications such as multiple myeloma, non-Hodgkin's lymphoma, chronic lymphocytic leukemia, acute myeloid leukemia and myelodysplastic syndromes.

Cyclacel Pharmaceuticals Reports Survival Data From Phase 2 Sapacitabine Study ...  -  ‎Oct 29, 2009‎
PipelineReview.com (press release)...for the treatment of acute myeloid leukemia in the elderly, myelodysplastic syndromes and lung cancer and in Phase 1 in combination with seliciclib. ...

Bone marrow donations could become profitable as a result of lawsuit  -  ‎Nov 16, 2009‎
Baby ChumsAn overturn of the ban could have a large impact on physicians, donors, and especially patients, including those with myelodysplastic syndromes (MDS) and ...

Cyclacel Pharmaceuticals Announces Second Quarter 2009 Financial ...  -  07 Aug 2009
GlobeNewsWire (press release)...for elderly patients with acute myeloid leukemia and myelodysplastic syndromes," said Spiro Rombotis, President and Chief Executive Officer of Cyclacel.

The MDS Foundation Says That NCCN Upgrades Epigenetic Drug VIDAZA ...  -  ‎Aug 5, 2009‎
Business Wire (press release)The Myelodysplastic Syndromes Foundation, Inc. is a multi-disciplinary, international organization devoted to the prevention, treatment, and study of the

CELG, TYPE, ROYL CRWENewswire Stock Highlights  -  ‎Aug 5, 2009‎
TransWorldNews (press release)Myelodysplastic syndromes (MDS) are a group of hematologic malignancies that affect approximately 300000 people worldwide. Myelodysplastic syndromes occur

'Universal' health care?  -  ‎Jul 30, 2009‎
The North Bay NuggetMy wife has MDS (Myelodysplastic Syndromes), the results of chemotherapy for acute leukemia. Her bone marrow makes few white cells, but she has been

NICE consultation ends in thumbs down for Celgene's Vidaza  -  ‎Aug 4, 2009‎
Pharma Times...back in March to treat myelodysplastic syndromes, including the subgroups chronic myelomonocytic leukaemia (CML) and acute myeloid leukaemia (AML).

Soliris(TM) (Eculizumab), The First and Only Therapy For The ...  -  ‎Jul 29, 2009‎
Canada NewsWire (press release)...(7) PNH has been identified more commonly among patients with disorders of the bone marrow, including aplastic anemia (AA) and myelodysplastic syndromes

Cyclacel Pharmaceuticals to Announce Second Quarter 2009 Financial ...  -  ‎Jul 31, 2009‎
GlobeNewsWire (press release)...for the treatment of acute myeloid leukemia in the elderly, myelodysplastic syndromes and lung cancer and in Phase 1 in combination with seliciclib.

CytRx's Tamibarotene Receives Positive Opinion From The Committee ...  -  ‎Jul 27, 2009‎
Medical News Today (press release)...myelodysplastic syndrome and certain solid tumors in the US, and multiple myeloma, myelodysplastic syndromes and solid tumors other than hepatocellular

PicksThatMove: www.PicksThatMove.com: "Picks that move" Alerts ...  -  ‎Jul 24, 2009‎
Trading Markets (press release)...for the treatment of acute myeloid leukemia in the elderly, myelodysplastic syndromes and lung cancer and in Phase 1 in combination with seliciclib.

St. Paul-Born Artist Ruben Trejo Dies In Spokane  -  ‎Jul 22, 2009‎
WCCOAccording to the National Cancer Institute there are several myelodysplastic syndromes, but they are characterized as diseases that cause bone marrow to not

Alexion Reports Second Quarter 2009 Results  -  ‎Jul 23, 2009‎
FOXBusinessThis study of more than 5000 patients demonstrated that PNH cells are found in the majority of patients with aplastic anemia, myelodysplastic syndromes and

CytRx's Tamibarotene Receives Positive Opinion from the Committee ...  -  ‎Jul 24, 2009‎
FOXBusiness...myelodysplastic syndrome and certain solid tumors in the US, and multiple myeloma, myelodysplastic syndromes and solid tumors other than hepatocellular

Hope and pray that you don't get sick  -  ‎Jul 12, 2009‎
Sun-Sentinel.comDoctors at the University of Florida Shands hospital eventually diagnosed him with myelodysplastic syndromes (MDS). It is a disorder in which bone marrow



Background information on Myelodysplastic Syndromes [When available]

The myelodysplastic syndromes (MDS, formerly known as "preleukemia") are a diverse collection of haematological conditions united by ineffective production of blood cells. Anemia requiring chronic blood transfusion is frequently present.

Search the web for more resources on Myelodysplastic Syndromes



Health Home | Conditions | Cancer | Medications | Surgery | Vaccines


The Cancer News Network


Disclaimer:

Contact a physician with regard to health concerns. Email requests for further health information will be discarded.

The materials contained on this Web site are for informational purposes only and do not constitute health or medical advice. Use of information on this site does not create or constitute any kind of agreement or contract between you and the owners or users of this site, the owners of the servers upon which it is housed, or anyone else who is in any way connected with this site.

Many links on cancernewsnetwork.org lead to other sites. cancernewsnetwork.org does not sponsor, endorse or otherwise approve of the materials appearing in such sites. Nor is CancerNewsNetwork.org responsible for dead or misdirected links.

IF YOU NEED A LINK OR TEXT REMOVED FROM THIS PAGE PLEASE CONTACT cancernewsnetwork (at) live.com.
We will do our best to accommodate your request.



COPYRIGHT 2009 CANCERNEWSNETWORK | Privacy